Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Nicotine induces cell proliferation by β-arrestin–mediated activation of Src and Rb–Raf-1 pathways
Piyali Dasgupta, … , Eric Haura, Srikumar Chellappan
Piyali Dasgupta, … , Eric Haura, Srikumar Chellappan
Published August 1, 2006
Citation Information: J Clin Invest. 2006;116(8):2208-2217. https://doi.org/10.1172/JCI28164.
View: Text | PDF | Corrigendum
Research Article Oncology Article has an altmetric score of 6

Nicotine induces cell proliferation by β-arrestin–mediated activation of Src and Rb–Raf-1 pathways

  • Text
  • PDF
Abstract

Recent studies have shown that nicotine, a component of cigarette smoke, can stimulate the proliferation of non-neuronal cells. While nicotine is not carcinogenic by itself, it has been shown to induce cell proliferation and angiogenesis. Here we find that mitogenic effects of nicotine in non–small cell lung cancers (NSCLCs) are analogous to those of growth factors and involve activation of Src, induction of Rb–Raf-1 interaction, and phosphorylation of Rb. Analysis of human NSCLC tumors show enhanced levels of Rb–Raf-1 complexes compared with adjacent normal tissue. The mitogenic effects of nicotine were mediated via the α7-nAChR subunit and resulted in enhanced recruitment of E2F1 and Raf-1 on proliferative promoters in NSCLC cell lines and human lung tumors. Nicotine stimulation of NSCLC cells caused dissociation of Rb from these promoters. Proliferative signaling via nicotinic acetylcholine receptors (nAChRs) required the scaffolding protein β-arrestin; ablation of β-arrestin or disruption of the Rb–Raf-1 interaction blocked nicotine-induced proliferation of NSCLCs. Additionally, suppression of β-arrestin also blocked activation of Src, suppressed levels of phosphorylated ERK, and abrogated Rb–Raf-1 binding in response to nicotine. It appears that nicotine induces cell proliferation by β-arrestin–mediated activation of the Src and Rb–Raf-1 pathways.

Authors

Piyali Dasgupta, Shipra Rastogi, Smitha Pillai, Dalia Ordonez-Ercan, Mark Morris, Eric Haura, Srikumar Chellappan

×

Figure 4

β-arrestin–1 mediates Src activation upon nAChR signaling.

Options: View larger image (or click on image) Download as PowerPoint
β-arrestin–1 mediates Src activation upon nAChR signaling.
(A) Transfect...
(A) Transfection of β-arrestin–1 siRNA inhibited nicotine-induced, but not serum-induced, S-phase entry in A549 cells. A nontargeting siRNA sequence was used as a control for all experiments. (B) Western blot analysis showing the suppression of β-arrestin in A549 cells upon transfection of β-arrestin–1 siRNA. Ablation of β-arrestin–1 significantly reduced nicotine-induced phosphorylated Src and phosphorylated ERK levels, whereas levels of total Src and ERK remained constant. Western blotting for actin served as the loading control. (C) Densitometric analysis was performed to quantitate the results obtained by Western blotting. (D) Nicotine induced the binding of Src to β-arrestin in A549 cells. Transfection of β-arrestin–1 siRNA abrogated the binding of c-Src to β-arrestin, whereas a nontargeting siRNA sequence had no effect. (E) Nicotine-induced stimulation of quiescent A549 cells for 15 minutes led to the binding of β-arrestin–1 to Src and to β-nAChR. (F) The binding of β-arrestin to nAChRs seen in E was confirmed by IP using β-nAChR antibody and Western blotting for β-arrestin. (G) Transfection of β-arrestin–1 siRNA inhibited Rb–Raf-1 binding in nicotine-stimulated A549 lysates, whereas a non-targeting siRNA sequence had no effect. No effect of β-arrestin–1 siRNA was seen on serum-induced Rb–Raf-1 binding in A549 cells.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Referenced in 2 patents
83 readers on Mendeley
See more details